Leadership - Pharma8k's

Centessa Pharmaceuticals (CNTA) Appoints New CEO, Advances Orexin Portfolio with ORX750 Phase 2a Data

11 Dec 2025 SEC Filing 8-K Leadership $CNTA

Centessa Pharmaceuticals (CNTA) Appoints New CEO, Advances Orexin Portfolio with ORX750 Phase 2a Data

Centessa Pharmaceuticals (CNTA) appointed Mario Alberto Accardi PhD as CEO effective January 1, 2026, and disclosed Phase 2a data for ORX750 in narcolepsy.

BioCryst Pharmaceuticals (BCRX) Announces Board Leadership Transition: Hutson Retires, Milano Elected Chair

11 Dec 2025 SEC Filing 8-K Leadership $BCRX

BioCryst Pharmaceuticals (BCRX) Announces Board Leadership Transition: Hutson Retires, Milano Elected Chair

BioCryst Pharmaceuticals (BCRX) announced the retirement of Nancy J. Hutson, Ph.D., from its Board of Directors and the election of Vincent J. Milano as the next Chair.

Factual headline with ticker: Apimeds Pharmaceuticals US, Inc. (APUS) Two Directors Resign

10 Dec 2025 SEC Filing 8-K Leadership $APUS

Factual headline with ticker: Apimeds Pharmaceuticals US, Inc. (APUS) Two Directors Resign

Apimeds Pharmaceuticals US, Inc. (APUS) announced two directors resigned from its board on December 5, 2025, according to an SEC 8-K filing.